167 related articles for article (PubMed ID: 29130688)
1. From Classification to Regression Multitasking QSAR Modeling Using a Novel Modular Neural Network: Simultaneous Prediction of Anticonvulsant Activity and Neurotoxicity of Succinimides.
Antanasijević D; Antanasijević J; Trišović N; Ušćumlić G; Pocajt V
Mol Pharm; 2017 Dec; 14(12):4476-4484. PubMed ID: 29130688
[TBL] [Abstract][Full Text] [Related]
2. Chemoinformatics for rational discovery of safe antibacterial drugs: simultaneous predictions of biological activity against streptococci and toxicological profiles in laboratory animals.
Speck-Planche A; Kleandrova VV; Cordeiro MN
Bioorg Med Chem; 2013 May; 21(10):2727-32. PubMed ID: 23582445
[TBL] [Abstract][Full Text] [Related]
3. Multitasking models for quantitative structure-biological effect relationships: current status and future perspectives to speed up drug discovery.
Speck-Planche A; Cordeiro MN
Expert Opin Drug Discov; 2015 Mar; 10(3):245-56. PubMed ID: 25613725
[TBL] [Abstract][Full Text] [Related]
4. New insights toward the discovery of antibacterial agents: multi-tasking QSBER model for the simultaneous prediction of anti-tuberculosis activity and toxicological profiles of drugs.
Speck-Planche A; Kleandrova VV; Cordeiro MN
Eur J Pharm Sci; 2013 Mar; 48(4-5):812-8. PubMed ID: 23376211
[TBL] [Abstract][Full Text] [Related]
5. Multi-Target QSAR Approaches for Modeling Protein Inhibitors. Simultaneous Prediction of Activities Against Biomacromolecules Present in Gram-Negative Bacteria.
Speck-Planche A; Cordeiro MN
Curr Top Med Chem; 2015; 15(18):1801-13. PubMed ID: 25961517
[TBL] [Abstract][Full Text] [Related]
6. QSAR and 3D-QSAR studies applied to compounds with anticonvulsant activity.
Garro Martinez JC; Vega-Hissi EG; Andrada MF; Estrada MR
Expert Opin Drug Discov; 2015 Jan; 10(1):37-51. PubMed ID: 25297377
[TBL] [Abstract][Full Text] [Related]
7. In silico assessment of the acute toxicity of chemicals: recent advances and new model for multitasking prediction of toxic effect.
Kleandrova VV; Luan F; Speck-Planche A; Cordeiro MN
Mini Rev Med Chem; 2015; 15(8):677-86. PubMed ID: 25694074
[TBL] [Abstract][Full Text] [Related]
8. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
[TBL] [Abstract][Full Text] [Related]
9. QSAR-Co: An Open Source Software for Developing Robust Multitasking or Multitarget Classification-Based QSAR Models.
Ambure P; Halder AK; González Díaz H; Cordeiro MNDS
J Chem Inf Model; 2019 Jun; 59(6):2538-2544. PubMed ID: 31083984
[TBL] [Abstract][Full Text] [Related]
10. Quantitative structure-activity relationship models for compounds with anticonvulsant activity.
Bellera CL; Talevi A
Expert Opin Drug Discov; 2019 Jul; 14(7):653-665. PubMed ID: 31072145
[No Abstract] [Full Text] [Related]
11. Toward an optimal procedure for variable selection and QSAR model building.
Yasri A; Hartsough D
J Chem Inf Comput Sci; 2001; 41(5):1218-27. PubMed ID: 11604021
[TBL] [Abstract][Full Text] [Related]
12. Quantitative structure-activity relationship: promising advances in drug discovery platforms.
Wang T; Wu MB; Lin JP; Yang LR
Expert Opin Drug Discov; 2015 Dec; 10(12):1283-300. PubMed ID: 26358617
[TBL] [Abstract][Full Text] [Related]
13. Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
Prado-Prado FJ; Martinez de la Vega O; Uriarte E; Ubeira FM; Chou KC; González-Díaz H
Bioorg Med Chem; 2009 Jan; 17(2):569-75. PubMed ID: 19112024
[TBL] [Abstract][Full Text] [Related]
14. ANN-QSAR model for virtual screening of androstenedione C-skeleton containing phytomolecules and analogues for cytotoxic activity against human breast cancer cell line MCF-7.
Prakash O; Khan F; Sangwan RS; Misra L
Comb Chem High Throughput Screen; 2013 Jan; 16(1):57-72. PubMed ID: 23030276
[TBL] [Abstract][Full Text] [Related]
15. Latest advances in molecular topology applications for drug discovery.
Zanni R; Galvez-Llompart M; García-Domenech R; Galvez J
Expert Opin Drug Discov; 2015; 10(9):945-57. PubMed ID: 26134383
[TBL] [Abstract][Full Text] [Related]
16. Optimizing drug discovery using multitasking models for quantitative structure-biological effect relationships: an update of the literature.
Kleandrova VV; Cordeiro MNDS; Speck-Planche A
Expert Opin Drug Discov; 2023; 18(11):1231-1243. PubMed ID: 37639708
[TBL] [Abstract][Full Text] [Related]
17. Pharmacophore modeling, 3D-QSAR, and in silico ADME prediction of N-pyridyl and pyrimidine benzamides as potent antiepileptic agents.
Malik R; Mehta P; Srivastava S; Choudhary BS; Sharma M
J Recept Signal Transduct Res; 2017 Jun; 37(3):259-266. PubMed ID: 27607834
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds.
Ventura C; Latino DA; Martins F
Eur J Med Chem; 2013; 70():831-45. PubMed ID: 24246731
[TBL] [Abstract][Full Text] [Related]
19. Multi-Layer Identification of Highly-Potent ABCA1 Up-Regulators Targeting LXRβ Using Multiple QSAR Modeling, Structural Similarity Analysis, and Molecular Docking.
Chen M; Yang F; Kang J; Yang X; Lai X; Gao Y
Molecules; 2016 Nov; 21(12):. PubMed ID: 27916850
[TBL] [Abstract][Full Text] [Related]
20. Rational drug design for anti-cancer chemotherapy: multi-target QSAR models for the in silico discovery of anti-colorectal cancer agents.
Speck-Planche A; Kleandrova VV; Luan F; Cordeiro MN
Bioorg Med Chem; 2012 Aug; 20(15):4848-55. PubMed ID: 22750007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
